• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 17, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Novotech COVID-19 clinical trial clients access new Asia-Pacific fast-track processes

Bioengineer by Bioengineer
April 23, 2020
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A Novotech client’s COVID-19 trial was just approved in under 9 days in South Korea

IMAGE

Credit: Novotech

The Asia-Pacific’s largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients’ clinical trials with expedited review processes for treatment and vaccine candidates.

A Novotech client’s COVID-19 trial was just approved in under 9 days in South Korea.

The South Korean Ministry of Food and Drug Safety (MFDS) has announced “GO-expedite” program where they are expediting the review process for COVID-19 treatment and vaccine trials with specific timelines.

Other countries are also fast-tracking COVID-19 trial reviews including:

  • India: review/approval in 10 working days  

  • Thailand: review/approval in 15 working days

  • Malaysia: review/approval in 20 working days

Novotech Executive Director Asia Operations Dr. Yooni Kim said she was pleased to see such a rapid response in the region to support vital research.

“We are seeing an increase in demand from biotechnology sponsors for studies in the Asia-Pacific region because of the speed and quality available here. This expedited review process will further support the race for COVID-19 treatments.”

For the latest updates on the Asia-Pacific clinical trial landscape see our Data Bulletins (updated weekly).

About Novotech – https://novotech-cro.com

Novotech is internationally recognized as the leading regional full-service contract research organization (CRO) in Asia-Pacific. Novotech has been instrumental in the success of over a thousand Phase I – IV clinical trials for biotechnology companies. 

Novotech was established in 1996, with offices in 11 locations across the region, and site partnerships with major health institutions.
 

Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech obtained the ISO 27001 certification which is the best-known standard in the ISO family providing requirements for an Information Security Management System. Together with the ISO 9001 Quality Management system, Novotech aims at the highest IT security and quality standards for patients and biotechnology companies.  
 

For RFP enquiries: Please fill out the form available at https://novotech-cro.com/talk-to-an-expert

###

Media Contact
Kate Johnson
[email protected]

Original Source

https://novotech-cro.com/news/novotech-covid-19-clinical-trial-clients-benefit-new-asia-pacific-fast-track-review-processes

Tags: BiologyBiotechnologycancerClinical TrialsImmunology/Allergies/AsthmaInfectious/Emerging DiseasesInternal MedicineMetabolism/Metabolic Diseasesneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

Unveiling Ancient Insights Behind Modern Cytoskeleton Evolution

Unveiling Ancient Insights Behind Modern Cytoskeleton Evolution

August 15, 2025
blank

Researchers Identify Molecular “Switch” Driving Chemoresistance in Blood Cancer

August 15, 2025

First Real-Time Recording of Human Embryo Implantation Achieved

August 15, 2025

Ecophysiology and Spread of Freshwater SAR11-IIIb

August 15, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    79 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    59 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Seismic Analysis of Masonry Facades via Imaging

Pediatric Pharmacogenomics: Preferences Revealed by Choice Study

Genkwanin Glycosides Boost Glucose Uptake in Fat

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.